Nonalcoholic fatty liver disease as a risk factor for cytomegalovirus hepatitis in an immunocompetent patient: A case report

Table 2 Hepatitis workup

Test	Result
Hepatitis A IgM	Negative
Hepatitis Be Antigen	Negative
Hepatitis Be antibody	Negative
Hepatitis C	Negative
Hepatitis E antibody IGG	Detected
Hepatitis E antibody IGM	Negative
HIV antibody	Negative
Blood culture	Negative
Urine culture	Negative
Pregnancy test, Urine	Negative
Serum CMV DNA PCR (normal range < 200.00 IU/mL)	13700 IU/mL
Cytomegalovirus IgM (normal range < 29.9 U/mL)	47.7AU/mL
Influenza A and B rapid test	Negative
Epstein-Barr virus DNA PCR (Negative)	Negative
HIV-1/2 antibody/antigen	Negative
SARS-COV-2 IGM/IGG	Negative
Acetaminophen (range 10-30 µg/mL)	< 10 µg/mL
Antinuclear antibodies	Negative
Anti-smooth muscle antibody	Negative
Anti-mitochondrial	Negative
Tissue transglutaminase antibody	Negative
Liver kidney microsomal assay (negative range ≤ 20.0 units)	< 20.0 units
Ferritin	384 ng/mL
Erythrocyte sedimentation rate (range 0-30.0 mm/h)	16 mm/h
24 h Urine Copper (3.0-45.0 µg/d)	48 µg/d
C-reactive protein (0.00-0.80 mg/dL)	5.8 mg/dL

CMV: Cytomegalovirus; PCR: Polymerase chain reaction; SARS-COV-2: Severe acute respiratory syndrome coronavirus; IGG: Immunoglobulin G.